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Abstract  1 
 MAP kinase and PI3K/Akt signalling pathways are commonly altered in 2 
colorectal carcinoma (CRC) leading to tumor growth due to increased cell proliferation 3 
and inhibition of apoptosis. Several species of the genus Hypericum are plants used in 4 
Portugal to prepare herbal teas to which digestive tract effects are attributed. In the 5 
present study, the antiproliferative and proapoptotic effects of the water extracts of H. 6 
androsaemum (HA) and H. perforatum (HP) were investigated in two human colon 7 
carcinoma-derived cell lines, HCT15 and CO115, which harbour activating mutations 8 
of KRAS and BRAF, respectively. Contrarily to HP, HA significantly inhibited cell 9 
proliferation and induced apoptosis in both cell lines. HA decreased BRAF and 10 
phospho-ERK expressions in CO115, but not in HCT15. HA also decreased Akt 11 
phosphorylation in CO115 and induced p38 and JNK in both cell lines. HA induced cell 12 
cycle arrest at S and G2/M phases as well as caspase-dependent apoptosis in both cell 13 
lines. Chlorogenic acid (CA), the main phenolic compound present in the HA extract 14 
and less represented in the HP water extract, did, however, not show any of those effects 15 
when used individually. In conclusion, water extract of HA, but not of HP, controlled 16 
CRC proliferation and specifically acted on mutant and not wild-type BRAF. This effect 17 
of HA was, however, not due to CA alone. 18 
 19 
 20 
Keywords: BRAF, Chlorogenic acid, Colorectal Carcinoma, Hypericum androsaemum, 21 
Hypericum perforatum, MAP kinases, PI3K/Akt Pathway 22 
23 
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Introduction 24 
 Environmental factors, many of which diet related, are responsible for 70-80% of 25 
total cases of colorectal carcinoma (CRC), an important health problem worldwide (1, 26 
2). To the two species of Hypericum (family Hypericaceae), Hypericum androsaemum 27 
(HA) and Hypericum perforatum (HP), used in this study (spontaneous in the north of 28 
Portugal) important medicinal properties have been attributed. H. perforatum (HP), also 29 
known as St. John’s wort, is the most studied of Hypericum species and it is known for 30 
its pharmacological antidepressant activities and its antiviral and antibacterial properties 31 
(3). The anticarcinogenic activity of HP has also been reported in several cancer cell 32 
types, although not in CRC cells (4-7). Its antitumor effects have been related with one 33 
of its main constituents, hypericin (8-10), that is, however, residual in the water extract 34 
(11).  H. androsaemum is less studied but it is the most frequently used in Portugal due 35 
to its diuretic, hepatoprotector, cholagogue, and also anti-kidney failure properties, as 36 
well as in the relief of digestive tract disorders (12, 13). Its anticarcinogenic activity has, 37 
to our knowledge, never been reported. Recent in vitro studies showed the antioxidant 38 
and hepatoprotective activities of HA water extract (14, 15). The effects of HA have 39 
been attributed, at least in part, to the presence of several flavonoids, such as quercetin 40 
and its glycosides, and phenolic acids, such as chlorogenic acid (15). Chlorogenic acid 41 
(CA) is distinctively more abundant in HA water extract than in HP water extract. HA 42 
water extract does not posses hypericin in its constitution (11). Plants containing a 43 
variety of phenolic compounds have been shown to play an important role as dietary 44 
antioxidants in cancer prevention (16, 17). However, evidence is increasing that the 45 
anticarcinogenic properties of plant food constituents is not only the result of their 46 
antioxidant activity. In fact, many of these constituents have been demonstrated to act 47 
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on multiple key elements in signalling pathways related to cellular proliferation and 48 
apoptosis (18, 19). 49 
 Activating mutations of KRAS, BRAF and/or PI3K have been found in more than 50 
50% of CRC cases and constitutively activate the mitogen-activated protein 51 
kinase/extracellular signal-regulated kinase (MAPK/ERK) and/or the 52 
phosphatidylinositol 3-kinase (PI3K)/Akt signalling pathways (20, 21). The constitutive 53 
activation of these pathways results in higher cell proliferation rates and in inhibition of 54 
apoptosis (20, 22-24). Since MAPK/ERK and PI3K/Akt pathways are involved in CRC 55 
progression and drug resistance, proteins associated with these pathways are good 56 
molecular therapeutic targets for drug discovery (25, 26). Also, the stress-activated 57 
protein kinases, c-Jun N-terminal kinase (JNK) and p38, are two other major MAPK 58 
pathways frequently deregulated in cancer, including CRC (26, 27). They are involved 59 
in the control of cell proliferation and apoptosis, therefore they may also be considered 60 
as potential targets for cancer therapy (28, 29). 61 
Since HA and HP are popularly consumed as herbal teas (water extract) for the 62 
relief of digestive tract disorders, and they contain quercetin (mainly as glycosides), 63 
which we have shown in a previous study to possess anticarcinogenic activity against 64 
colon cancer cells (30), the antiproliferative and proapoptotic effects of the water 65 
extracts of these two Hypericum plants were tested in two human colon cancer-derived 66 
cell lines, HCT15 and CO115. These cell lines harbour different activating mutations 67 
that affect both MAPK/ERK and/or PI3K/Akt pathways: HCT15 has a KRAS (G13D) 68 
mutation (31) while CO115 harbour a BRAF (V599E) mutation (32), being 69 
representative of many CRC cases. The involvement of stress induced kinases p38 and 70 
JNK, and apoptotic markers were also studied.  71 
 72 
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Materials and Methods  73 
 74 
Reagents and Antibodies  75 
All reagents and chemicals used were of analytical grade. Wortmannin (W), LY-76 
294,002 (LY), propidium iodide (PI), staurosporine, 3-(4,5-dimethylthiazol-2-yl)-2,5-77 
diphenyltetrazolium bromide (MTT) and chlorogenic acid (CA) were purchased from 78 
Sigma-Aldrich (St. Louis, MO, USA); PD-98059 (PD) was from Calbiochem (San 79 
Diego, CA, USA); zVAD-fmk was from Santa Cruz Biotechnology, Inc. (Santa Cruz, 80 
CA, USA). Stocks solutions of W, LY, PD and zVAD were made in dimethyl sulfoxide 81 
(DMSO) and aliquots were kept at -20 ºC. DMSO (0.5%, final concentration) was used 82 
in the other conditions (control and HA extract alone) to exclude any solvent effect.  83 
The primary antibodies, anti-phospho-Akt (Ser473), anti-Akt, anti-phospho-84 
PTEN (Ser380/Thr382/383), anti-PTEN, anti-p44/42 MAPK and anti-phospho-p38 85 
MAPK (Thr180/Tyr182) were purchased from Cell Signaling (Danvers, MA, USA); the 86 
anti-phospho-ERK, anti-Raf-B, anti-K-Ras, anti-PKC total, anti-PARP-1, anti-p38, anti-87 
phospho-JNK and anti-JNK were from Santa Cruz Biotechnology, Inc.; the anti-88 
caspase-3 was from Calbiochem (San Diego, CA, USA); and the anti-β-actin from 89 
Sigma-Aldrich. The secondary antibodies HRP donkey anti-rabbit and sheep anti-mouse 90 
were from GE Healthcare (Bucks, UK).  91 
 92 
Cell culture and conditions 93 
HCT15 and CO115 human colon carcinoma-derived cell lines were a gift from 94 
Dr. Raquel Seruca (IPATIMUP, University of Porto, Portugal) and were maintained in 95 
culture at 37 ºC in a humidified 5 % CO2 atmosphere in RPMI-1640 medium (Sigma-96 
Aldrich) supplemented with 10 mM HEPES, 0.1 mM pyruvate, 1 % antibiotic-97 
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antimycotic solution (Sigma-Aldrich) and 6 % fetal bovine serum (FBS; EU standard, 98 
Cambrex, Verviers, Belgium). Cells were seeded onto six (2 ml) and twelve (1 ml) well 99 
plates at a density of 0.75×10
5
 (HCT15) and 1.0×10
5
 (CO115) cells/ml. Incubations for 100 
48 h with different concentrations of the water extracts were performed for MTT, 101 
TUNEL and cell cycle analysis, and for 24 h and 48 h for western blot. 102 
 103 
Preparation of HA extract 104 
 Plants of H. androsaemum were cultivated at Canidelo, Northern of Portugal, in 105 
a farm owned by Cantinho das Aromaticas Lda., whereas H. perforatum were obtained 106 
from Mapprod Lda., Braga, Portugal; plants are kept in active bank under the 107 
responsibility of the respective companies. The aerial parts of the plants were collected 108 
in July 2008 for HA and in July 2009 for HP; then, they were air-dried before being 109 
subjected to the water extraction by infusion. Batches of dried plant material are 110 
maintained at -20 ºC under the responsibility of CITAB with the accession numbers 111 
HA102008 and HP072009, for HA and HP, respectively. The plant infusions were 112 
prepared by pouring 150 ml of boiling deionized water onto 2 g of air-dried plant 113 
material and allowing it to steep for 5 min. After filtering, the water extracts were 114 
lyophilized to dryness and yields in terms of initial crude plant material dry weight of 115 
27.0% (w/w) and 16.7% (w/w), for HA and HP, respectively, were obtained. Phenolic 116 
compounds were analyzed by HPLC as previously performed (12) and, for HA, a 117 
similar composition with a previous report of a water extract was obtained (15). The 118 
main phenolic compounds found in the plant water extracts differ in quantity between 119 
them. The following compounds are present. In HA: chlorogenic acid (CA) and isomer 120 
(3-O and 5-O-caffeoylquinic acid; 53.82 µg/mg), quercetin 3-galactoside (16.35 µg/mg), 121 
quercetin 3-glucoside (5.41 µg/mg), quercetin 3-rutinoside (2.73 µg/mg) and quercetin 122 
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(1.32 µg/mg). In HP: quercetin 3-rutinoside (38.07 µg/mg), quercetin 3-galactoside 123 
(16.00 µg/mg), quercetin 3-glucoside (6.47 µg/mg), chlorogenic acid (CA) and isomer 124 
(3-O and 5-O-caffeoylquinic acid; 5.75 µg/mg), quercetin (3.39 µg/mg), quercetin 3-125 
rhamnoside (0.24 µg/mg), amenthoflavone (0.33 µg/mg) and hypericin (0.03 µg/mg). 126 
CA is much more abundant in HA water extract than in the HP water extract where 127 
quercetin and related compounds are the most representative (11). 128 
 129 
Cell proliferation/viability assay 130 
MTT reduction assay was used to estimate the number of viable cells after 131 
treatment with Hypericum water extracts, as previously described (30). Cells were 132 
treated with different concentrations of water extracts and CA for 46 h followed by two 133 
hours in the presence of MTT (final concentration 0.5 mg/ml). Hydrogen chloride 0.04 134 
M in isopropanol was then used to dissolve the formazan crystals. The number of viable 135 
cells in each well was estimated by spectrophotometry. To discriminate between 136 
inhibition of cell proliferation (values between 0 and 100%) and induction of extensive 137 
cell death (negative values) the control values from the beginning of the treatment 138 
period (0 h) were subtracted from all samples collected after 48h of incubation, 139 
including the control. Results are presented as mean ± SEM of at least three 140 
independent experiments. 141 
 142 
Assessment of apoptosis by TUNEL assay 143 
 Cells treated with different concentrations of HA (with or without 20 µM 144 
zVAD) for 48 h were collected (both floating and attached cells) and fixed with 4% 145 
paraformaldehyde for 15 min at room temperature and then attached into a polylysine 146 
treated slide using a Shandon Cytospin 4 (Thermo Scientific, Waltham, MA, USA). 147 
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Cells were washed in PBS and permeabilized with 0.1% Triton X-100 in 0.1% sodium 148 
citrate for 2 min on ice. TUNEL (TdT mediated dUTP Nick End Labelling) assay was 149 
performed using a kit from Roche (Mannheim, Germany), following the manufacturer’s 150 
instructions. Cells were incubated with Hoechst for nuclei staining. The percentage of 151 
apoptotic cells was calculated from the ratio between TUNEL positive cells and total 152 
number of cells (nuclei staining with Hoechst), from a count higher than 500 cells per 153 
slide under a fluorescent microscope. Results are presented as mean ± SEM of at least 154 
three independent experiments. 155 
 156 
Protein extraction and western blot 157 
 After incubation periods, cells were first washed with PBS and then lysed for 15 158 
min at 4 ºC with ice-cold RIPA buffer (1% NP-40 in 150 mM NaCl, 50 mM Tris (pH 159 
7.5), 2 mM EDTA), supplemented with 20 mM NaF, 1 mM phenylmethylsulfonyl 160 
fluoride (PMSF), 20 mM Na2V3O4 and protease inhibitor cocktail (Roche, Mannheim, 161 
Germany). Protein concentration was quantified using a Bio-Rad DC protein assay 162 
(Bio-Rad Laboratories, Inc., Hercules, CA, USA) with BSA as a protein standard. 163 
Twenty micrograms of protein from each sample were separated by SDS gel 164 
electrophoresis and then electroblotted to a Hybond-P polyvinylidene difluoride 165 
membrane (GE Healthcare). Membranes were blocked in TPBS (PBS with 0.05% 166 
Tween-20) containing 5% (w/v) non-fat dry milk or BSA, incubated with the primary 167 
antibody followed by the secondary antibody conjugated with IgG horseradish 168 
peroxidase. Immunoreactive bands were detected using the Immobilon solutions 169 
(Millipore, Billerica, MA, USA) under a chemiluminescence detection system, the 170 
Chemi Doc XRS (Bio-Rad Laboratories, Inc.). Band area intensity was quantified using 171 
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the Quantity One software from Bio-Rad. β-actin was used as a loading control. Results 172 
are presented as mean ± SEM of at least three independent experiments.  173 
 174 
Cell Cycle analysis 175 
Cells were treated with HA for 48 h and then harvested (both floating and 176 
attached cells) by tripsinization. After centrifugation, cell pellets were washed in PBS, 177 
fixed with ethanol 70% at 4ºC for 15 min and rinsed with PBS. Cells were then 178 
incubated with staining solution (50µg/ml propidium iodide and 20µg/ml RNase A in 179 
PBS) at 37ºC for 15 min. Cell cycle progression was analyzed by flow cytometry using 180 
a Coulter Epics XL Flow Cytometer (Beckman Coulter Inc., Miami, FL, USA) counting 181 
at least 40,000 single cells per sample. Phases of cell cycle were fitted using the 182 
mathematical Watson Pragmatic model (33) with the FlowJo Analysis Software (Tree 183 
Star, Inc., Ashland, OR, USA). 184 
 185 
Statistical analysis 186 
 Student’s t-test or one-way ANOVA followed by the Student-Newman-Keuls 187 
test was used to perform statistical analysis for TUNEL, cell cycle and western blot 188 
data. GraphPad Prism 4.0 software (San Diego, CA, USA) was used and P-values ≤ 189 
0.05 were considered statistically significant.  190 
 191 
Results  192 
 193 
Effects of two Hypericum species on cell proliferation and apoptosis 194 
 To evaluate the anticancer potential of water extracts from H. perforatum and H. 195 
androsaemum their effects for 48h in the number of viable cells, in HCT15 and CO115 196 
Page 46 of 68Food & Function
   Xavier 10
human colon carcinoma-derived cell lines, were investigated using the MTT assay. As 197 
shown in Figure 1A, HCT15 and CO115 cell lines are more resistant to HP water 198 
extract than to HA water extract. The number of viable cells decreased remarkably with 199 
HP treatment only at concentrations above 200 µg/ml in both cell lines. The HA extract 200 
was more efficient in inhibiting cell proliferation in a concentration-dependent manner 201 
in both cell lines, with an IC50 (the concentration that inhibited cell growth by 50%) of 202 
around 85 µg/ml in HCT15 and 65 µg/ml in CO115 cells, compared to HP. At the 203 
highest concentrations tested of HA, extensive cell death was observed in both cell 204 
lines, as indicated by both the presence of significant amounts of floating cells and by 205 
PI staining (data not shown). Incubation of CRC cells with HA also significantly 206 
induced apoptosis in a concentration-dependent manner in both cell lines (Figure 1B), 207 
as shown by the TUNEL assay. Comparing both Hypericum water extracts, HA has, 208 
therefore, higher anticancer potential as compared to HP. 209 
In order to characterize effects of HA on signaling pathways related to 210 
proliferation and apoptosis, the IC50 concentration for each cell line (85 µg/ml for 211 
HCT15 and 65 µg/ml for CO115) and a concentration below this were used and their 212 
effects on the levels of relevant molecular targets characterized in subsequent 213 
experiments.  214 
 215 
Effect of chlorogenic acid (CA) on cell proliferation  216 
 H. androsaemum water extract was more efficient in inhibiting cell growth in 217 
both HCT15 and CO115 CRC cell lines than HP. In an attempt to find the compound 218 
responsible for these effects, the main phenolic present in this extract, chlorogenic acid 219 
(CA), which also distinguishes this extract from HP water extract that has a much lower 220 
concentration, was evaluated individually at different concentrations, using MTT assay. 221 
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CA is present at about 54 µg/mg in HA water extract, while in HP CA is present in 222 
smaller amounts (about 6 µg/mg, respectively). No effects were observed on cell 223 
proliferation in neither of the cell lines treated with CA up to 200 µM, which 224 
corresponds to a concentration 20 times higher than the one found in 100 µg/ml of HA 225 
water extract (Figure 2). It seems therefore that the inhibition of cell proliferation 226 
produced by HA is not due to CA alone. 227 
 228 
Effects of HA on PI3K/Akt and MAPK/ERK pathways  229 
Constitutive activations of MAPK/ERK and PI3K/Akt pathways are present in a 230 
large number of CRC cases, leading to an increase of proliferation and an inhibition of 231 
apoptosis (20). Phosphorylation of ERK and Akt, respectively, are indicators of their 232 
activation. As shown in Figure 3A, HA significantly decreased phospho-Akt protein 233 
level in CO115 cells, in a concentration-dependent manner, after 24 h of incubation. 234 
This effect was not observed in HCT15 since there was no detectable amounts of 235 
phospho-Akt in these cells (data not shown), which is in agreement with previous 236 
observations (30). As expected, reference inhibitors of PI3K, wortmannin (W) and LY-237 
294,002 (LY), also significantly decreased phospho-Akt levels (34). The effect of HA 238 
on phospho-PTEN, a negative regulator of PI3K/Akt pathway, was also tested. As 239 
shown in Figure 3B, HA did not change phospho-PTEN levels in HCT15. As previously 240 
reported (30), no detectable expression of PTEN was observed in CO115 cells (data not 241 
shown).  242 
 Concerning effects on the MAPK/ERK pathway, a significant decrease in 243 
phospho-ERK protein level was observed in CO115 cells, but not in HCT15, induced by 244 
the higher concentration of HA tested (Figure 3C). As expected, a significant reduction 245 
of phospho-ERK levels in both cell lines was also induced by PD-98059 (PD), a 246 
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reference inhibitor of the MAPK/ERK pathway (35). In addition, we also treated both 247 
cell lines with CA. This compound did not decrease phospho-Akt or phospho-ERK 248 
protein levels at 10 and 100 µM in both cell lines (data not shown). 249 
  250 
Effects of HA on BRAF and KRAS levels   251 
 Subsequently, since KRAS activates both MAPK/ERK and PI3K/Akt pathways 252 
and BRAF activates MAPK/ERK pathway, effects of HA on the protein expression of 253 
KRAS and BRAF oncogenes were studied. As shown in Figure 4A, the higher HA 254 
concentration tested was able to significantly decrease the levels of BRAF in CO115 255 
(cells with mutant BRAF). In HCT15 cells, which express the wild type BRAF, no 256 
effect of HA on BRAF protein expression was observed. No significant changes were 257 
observed in wild type or mutant KRAS levels induced by HA (Figure 4B). CA, when 258 
used individually, did not change KRAS or BRAF levels at 10 and 100 µM in both cell 259 
lines (data not shown). 260 
 261 
Effects of HA on p38 and JNK pathways  262 
 The effect of HA on p38 and JNK signalling pathways, two stress-activated 263 
protein kinases that are involved in the control of proliferation and induction of 264 
apoptosis (27), were also studied. Our results showed a remarkable induction of 265 
phospho-p38 expression at both concentrations tested and of phospho-JNK expression 266 
mainly at the higher concentration tested after 48 h in both cell lines (Figure 5A and 267 
5B).  268 
 269 
Effects of HA on cell cycle and death mechanisms  270 
Page 49 of 68 Food & Function
   Xavier 13
 As shown in Figure 1B with TUNEL assay, p53-mutated HCT15 cells are more 271 
resistant to apoptosis induction by HA than the p53-wild type CO115 cells. 272 
Corroborating these results, when cell cycle analysis was performed, the sub-G1 273 
fraction of cells (indicative of DNA fragmentation typical of apoptosis) was 274 
considerably higher in CO115 as compared with HCT15, when treated with HA (Figure 275 
6A, 6C). 276 
In order to verify the role of caspase activation on the apoptotic effect of the HA 277 
water extract, caspase-3 and Poly (ADP-ribose) polymerase-1 (PARP-1) expressions by 278 
western blot were studied. As shown in Figure 5C, HA increased cleaved caspase-3 and 279 
cleaved PARP-1 in CO115 cells. In HCT15, we did not observe cleaved caspase-3 or 280 
cleaved PARP-1, although a decrease in total caspase-3 and PARP-1 were detected. A 281 
higher expression level of total PARP-1 was observed in HCT15 as compared to 282 
CO115. The cleavage of caspase-3 and PARP-1 were also induced by staurosporine, an 283 
apoptotic inducer used here as positive control, in both cell lines (data not shown).   284 
 In order to confirm the role of caspase activation on apoptosis induction by HA, 285 
cells were incubated in the presence of the general caspase inhibitor zVAD, and 286 
apoptotic cells analysed by the TUNEL assay. As shown in Figure 5D, zVAD was able 287 
to prevent apoptosis induction by HA in both cell lines.  288 
The ability of HA to inhibit cell cycle was also confirmed by the cell cycle 289 
analysis. As shown in Figure 6A and 6B, HA induced both S phase and G2/M phase 290 
arrest in a concentration-dependent manner in both cell lines. The effect was more 291 
pronounced in the apoptosis-resistant HCT15 cell line. 292 
 293 
Discussion  294 
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 In the present study, the potential anticancer effects of water extracts of the 295 
medicinal plants H. androsaemum and H. perforatum, as well as, the main phenolic 296 
constituent present in HA extract, chlorogenic acid (CA), were studied in HCT15 and 297 
CO115, a KRAS and BRAF mutant human colorectal-derived cell lines. HA efficiently 298 
inhibited cell proliferation and induced apoptosis in a concentration-dependent manner 299 
in both cell lines. CO115 cells showed to be more sensitive to HA extract (IC50 ~65 300 
µg/ml) when compared with HCT15 (IC50 ~85 µg/ml). As far as we know, this is the 301 
first report of the anticancer effect of H. androsaemum water extract in CRC, which is 302 
popularly used in Portugal to treat problems of the gastrointestinal tract. The extract HP 303 
did not show significant effect on cell growth in neither of the cell lines. Previously, we 304 
reported that quercetin has antiproliferative effects on these colorectal cancer cells (30), 305 
and since HP water extract is rich in quercetin and related compounds, this result was 306 
somewhat surprising. Anticarcinogenic activities have been found for H. perforatum in 307 
other cell types (4-7) being related with one of its main constituents, hypericin (8-10), 308 
which is present in HP water extract (although in very small amounts) but not in the 309 
water extract of HA (11, 36). These results suggest that the anticancer effects observed 310 
for HA reflect the presence of other compounds in this species. We, therefore, studied 311 
the antiproliferative effect of the CA, which is much more abundant in HA than HP. 312 
However, when used alone this compound did not have any effect on cell proliferation 313 
in neither of the cell lines, which indicates that the HA’s effects are not due to its major 314 
phenolic compound, CA. Thus, other compounds or a synergism between the 315 
compounds present in the water extract of HA may be responsible for the HA effects. 316 
The differences in the genetic background of the two cell lines used allowed the 317 
study of the relevance of KRAS mutation versus BRAF mutation for HA’s effects. In 318 
CO115 (that harbour a BRAF mutation and overexpress Akt) a significant decrease of 319 
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phospho-Akt expression was observed in a HA concentration-dependent manner. These 320 
results show the ability of HA to decrease PI3K/Akt signalling probably by inhibiting 321 
PI3K activity, as also shown for some individual flavonoids, such as quercetin (30, 34, 322 
37). HA was also able to decrease MAPK/ERK signalling in CO115, as shown by a 323 
significant decrease in the phospho-ERK expression levels. Importantly, HA also 324 
decreased BRAF expression in these cells. Since HA did not affect the expression of 325 
phospho-ERK or BRAF in HCT15, our results indicate that the HA water extract affects 326 
the MAPK pathway at the level of mutant BRAF (Figure 7), which was confirmed by a 327 
decrease in mutant BRAF cell proliferation (CO115) versus no effect on wild-type (wt) 328 
BRAF cells (HCT15) at 60 µg/ml. Previous studies have shown that pharmacologic 329 
inhibition of RAF is highly effective at inhibiting the growth of BRAF mutant CRC 330 
cells (38). Moreover, recent reports show that RAF inhibitors block MAPK signalling in 331 
tumor cells harbouring mutant BRAF but activate this pathway in cells harbouring wt 332 
BRAF, emphasizing the importance of inhibiting specifically mutant BRAF to avoid 333 
secondary effects (39, 40). CA, the main phenolic compound present in HA water 334 
extract, has, however, no effect on levels of phospho-Akt, phospho-ERK or BRAF in 335 
CO115 cells. 336 
Regarding the RAS oncogene, no changes on the levels of KRAS were observed 337 
by HA. Previously, we showed that quercetin, at around 20µM, inhibits cell 338 
proliferation in association with a decrease in KRAS levels (30). Although the HA 339 
extract contains quercetin and glycosides of quercetin, their concentrations are low (less 340 
than 5µM), which may explain the lack of effect of HA on KRAS. The HA-induced 341 
inhibition of cell proliferation and increased apoptosis in HCT15 KRAS mutated cells 342 
seems not to result from effects on MAPK/ERK or PI3K/Akt signalling.  343 
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The effect of HA on the other two major MAPK pathways, the p38 and JNK, 344 
were also studied, since these stress-activated kinases may be involved in the control of 345 
proliferation and/or apoptosis (27, 41). HA significantly induced the phosphorylation of 346 
p38 and JNK in both cell lines (Figure 7). The effects on these two pathways could 347 
explain the decreased on cell proliferation and cell cycle arrest. An induction of 348 
caspase-3 and PARP-1 cleavage was also observed in CO115 when incubated with HA. 349 
The induction of JNK by HA may contribute to the activation of the mitochondrial 350 
caspase cascade (28) and lead to the high levels of caspase-dependent apoptosis 351 
observed in CO115. On other hand, cleavage of caspase-3 or PARP-1 was not observed 352 
in HCT15 despite the induction of JNK. That probably happened because the 353 
percentage of apoptosis induction by HA is low (about 5%) in HCT15 cells. 354 
Nevertheless, a decrease of total caspase 3 and PARP-1 protein levels, as well as 355 
prevention of apoptosis by the caspase inhibitor zVAD were observed, which indicates 356 
that apoptosis induction is also caspase-dependent in this cell line. The resistance to 357 
apoptosis of HCT15 cells as compared to CO115 cells was also shown previously (30, 358 
42) and may be explained by its p53 mutation status (31, 43, 44). In the p53-mutated 359 
HCT15 cells S-phase and G2/M-phase cell cycle arrest were more pronounced than 360 
induction of apoptosis, whereas the contrary was observed in the p53-wild type CO115 361 
cells. 362 
Studies with CA in skin cancer have shown that this phenolic acid has an anti-363 
inflammatory effect, interfering with NF-kβ activation and COX-2 activity, and has an 364 
inhibitory effect on skin cancer promotion (45, 46). However, studies in CRC agree 365 
with our results where no effect on colonic cell proliferation has been observed for CA 366 
(46, 47). In an attempt to identify the active compound(s) responsible for the HA 367 
effects’ on BRAF and phospho-ERK levels, a fractionation of the HA water extract was 368 
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performed with ethanol and methanol. The soluble and insoluble fractions of HA extract 369 
on both methanol and ethanol (20 mg lyophilized water extract per ml of solvent) were 370 
tested in cells (at same concentrations as those in the IC50 concentration of the crude 371 
extract). None of the fractions were able to significantly affect BRAF or phospho-ERK 372 
expression (data not shown). It seems, therefore, that the effects of HA water extract are 373 
due to a synergism between compounds, which explain why after fractionation of the 374 
extract the effect is lost.    375 
In conclusion, our study shows that the water extract of H. androsaemum 376 
inhibits cell proliferation and induces apoptosis in CRC-derived cell lines more 377 
efficiently than that of H. perforatum. Of particularly interest, the effects of HA involve 378 
a specific inhibition of mutant BRAF, which leads to an inhibition of MAPK/ERK 379 
pathway in BRAF mutant cells but not in wt BRAF cells. Inhibition of PI3K/Akt 380 
pathway, as well as, an induction of both p38 and JNK pathways may also contribute to 381 
the anticancer activity of HA. Chlorogenic acid, the main phenolic compound present in 382 
the HA extract, showed not to be responsible for the anticancer effects observed for the 383 
extract. These data add H. androsaemum to the list of plants with potential to be 384 
included in dietary strategies for the control of CRC progression, particularly for tumors 385 
presenting BRAF mutations. 386 
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Figure Legends 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. (A) Effects of different concentrations of water extracts of Hypericum 
perforatum and Hypericum androsaemum on cell viability/proliferation assessed by 
MTT reduction. (B) Effect of Hypericum androsaemum on apoptosis assessed by 
TUNEL assay, for 48 h, in HCT15 and CO115 cells. Values are mean ± SEM of at least 
3 independent experiments. ** P≤ 0.01 and *** P≤ 0.001 when compared to control. In 
A: line represents the inhibition of 50% of cell proliferation (IC50); the negative value 
mean that the cells reduction capacity after 48 h in that condition was below than the 
one obtained in the control in the beginning of the treatment period (0 h), being a 
indirect indication of cell death by necrosis. 
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Figure 2. Effects of different concentrations of chlorogenic acid on cell 
viability/proliferation assessed by MTT reduction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Effects of Hypericum androsaemum (HA) for 24 h on the levels of phospho-
Akt in CO115 cells (A), phospho-PTEN in HCT15 cells (B) and phospho-ERK in 
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HCT15 and CO115 cells (C) at 85 µg/ml (HA85), 65 µg/ml (HA65) and 45 µg/ml 
(HA45), using western blot. β-Actin was used as loading control. Wortmannin 1 µM 
(W1) and LY-294,002 20 µM (LY20) were used as a reference inhibitor of PI3K and 
PD-98059 50 µM (PD50) was used as a reference inhibitor of phospho-ERK. Values are 
mean ± SEM of at least 3 independent experiments. * P≤ 0.05,  ** P≤ 0.01 and *** P≤ 
0.001 when compared to control.  
 
 
 
Figure 4. Effects of Hypericum androsaemum (HA) for 24 h on BRAF (A) and KRAS 
(B) levels in HCT15 and CO115 cells at 85 µg/ml (HA85), 65 µg/ml (HA65) and 45 
µg/ml (HA45), using western blot. β-Actin was used as loading control. Values are 
mean ± SEM of at least 3 independent experiments. * P≤ 0.05 when compared to 
control. 
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Figure 5. Effects of Hypericum androsaemum (HA) for 48 h on the levels of phospho-
p38 (A), phospho-JNK (B) and apoptosis (C, D) in HCT15 and CO115 cells at 85 
µg/ml (HA85), 65 µg/ml (HA65) and 45 µg/ml (HA45). In A, B and C, levels of 
proteins were studied by western bloting. β-Actin was used as loading control. Images 
are representative of at least 3 independent experiments. In D, the effect of HA alone or 
in combination with 20 µM z-VAD-fmk (zVAD) on apoptosis was measured by the 
TUNEL assay. Values are mean ± SEM of at least 3 independent experiments. ** P≤ 
0.01 and *** P≤ 0.001 when compared to control (CT); 
##
 P≤ 0.01 when compared to 
zVAD alone; 
++
 P≤ 0.01 and 
+++
 P≤ 0.001 between each other. 
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Figure 6. Effects of Hypericum androsaemum (HA) for 48 h on cell cycle progression 
in HCT15 and CO115 cells at 45 µg/ml (HA45), 65 µg/ml (HA65) and 85 µg/ml 
(HA85) assessed by flow cytometry. (A) Distribution of single cells through the phases 
of cell cycle of a representative experiment. The effects of HA on cell cycle progression 
(B) and in the percentage of sub-G1 fraction (C) of 3 independent experiments are 
Page 65 of 68 Food & Function
   Xavier 29
shown. Values are mean ± SEM. * P≤ 0.05, ** P≤ 0.01 and *** P≤ 0.001 when 
compared to control. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Proposed model for the inhibition of cell proliferation and induction of 
apoptosis in colon cancer cells by Hypericum androsaemum (HA), in particular with 
effects on PI3K/Akt, MAPK/ERK, JNK and p38 signaling pathways. The anticancer 
effect of HA could be due to an inhibition of PI3K/Akt pathway, a decrease on BRAF 
mutation leading to an inhibition of MAPK/ERK pathway and an induction of both p38 
and JNK signalling.  
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Hypericum androsaemum water extract inhibits proliferation in human 
colorectal cancer cells through effects on MAP kinases and PI3K/Akt pathway 
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 Hypericum androsaemum water extract has anticancer potential inhibiting MAP 
kinase pathway through effects on mutant BRAF. 
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